Health & Healthcare

Corporate stories about Health & Healthcare across 3BL's network.

Latest in Health & Healthcare

Merck Helps To Improve Diversity in Clinical Trials Through Beacon of Hope
Increasing diversity in clinical trials plays a crucial role in helping to understand how a broad range of human bodies may respond to treatments.
Merck Is Collaborating To Address Antimicrobial Resistance
Antibiotics have transformed health care and saved countless lives. But rising levels of antimicrobial resistance (AMR) can make current antibiotics less effective.
Discovery Education, the American Heart Association, and the National Football League Engage Students in Fitness and Education Leading Up to Super Bowl LVIII
The American Heart Association and the National Football League (NFL) in collaboration with Discovery Education present new ways to engage students in fitness.
One Size Does Not Fit All: The Future of Clinical Trials
Our diversity initiative is just one aspect of continuing efforts to enhance health equity, expand access and affordability, and remove barriers to life-improving technology and scientific innovation.
The Toxicological Risk Status of PFAS
Following a published article earlier in the year regarding PFAS and Product Liability, Antea Group consultants Caron Koll and Jack Sheldon collaborated for a second time on a new article with the American Bar Association (ABA).
Albertsons Cos. Wants To Help Treat Opioid Use Disorder
Albertsons Cos. is making it easier for those with opioid use disorder to get treatment through its pharmacies.
Rutgers University and Quest Diagnostics Double H.O.P.E. Clinic Capacity With Expanded Collaboration
Rutgers University and Quest Diagnostics are expanding their collaboration to further improve access to critical primary care services for uninsured and underinsured patients of the university’s Health Outreach Practice Experience (H.O.P.E.) Clinic in Plainfield, NJ.
Viatris Announces U.S. FDA Tentative Approval of a Paediatric Formulation of Abacavir (ABC)/Dolutegravir (DTG)/Lamivudine (3TC), a Once-Daily Treatment for Children Living With HIV
Viatris Inc. today announced U.S. Food and Drug Administration (FDA) tentative approval for a New Drug Application for abacavir 60 mg/dolutegravir 5 mg/lamivudine 30 mg tablets for oral suspension for the treatment of HIV-1 infection in paediatric patients.
Neurinnov Is Transforming Tetraplegic Patient Care With Cadence
We are excited to share the latest developments from Neurinnov, a company working to restore hand movements for patients with complete tetraplegia following high-level spinal cord injury.
Direct Relief and The Pfizer Foundation Support 19 Programs To Improve Infectious Disease Care in the United States
Direct Relief today announced the recipients of the Innovation Awards in Community Health: Addressing Infectious Disease in Underserved Communities. Grants totaling more than $4.5 million will go to 19 U.S. safety-net community healthcare providers